Efficacy of Intravenous Glyco-P® in Patients Undergoing Procedure That Require Anesthesia Service

NCT02102542 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2014-04-03

No results posted yet for this study

Summary

This observational study was designed to prove clinical efficacy of the well known "glycopyrrolate" which is considered an orphan drug in Thailand. Since the medication has never been officially used in Thai people and this particular brand "Glyco-P" which was made in India has never been officially proven of its efficacy in Thai people. The study was aimed to prove if this Glyco-P can modestly increase patient's heart rate, decrease secretion and safely used in combination with neostigmine for reversal of non-depo muscle relaxant drugs.

Conditions

  • Hypersalivation
  • Prevention of Drooling
  • Bradycardia
  • Reversal of Muscle Relaxants

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2013-03-31
Completion
2013-04-30

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02102542 on ClinicalTrials.gov